Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
LPDX > SEC Filings for LPDX > Form 8-K on 6-Aug-2013All Recent SEC Filings

Show all filings for LIPOSCIENCE INC

Form 8-K for LIPOSCIENCE INC


6-Aug-2013

Results of Operations and Financial Condition, Financial Statements and Exhibits


Item 2.02 Results of Operations and Financial Condition.

On August 6, 2013, LipoScience, Inc. (the "Registrant") issued a press release announcing its financial results for the quarter ended June 30, 2013. A copy of this press release is furnished herewith as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02, and Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Registrant's filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) Resignation of Richard O. Brajer as President, Chief Executive Officer and Director On August 1, 2013, Richard O. Brajer, President and Chief Executive Officer and a director of the Registrant, resigned his employment with the Registrant and resigned as a member of the Board of Directors of the Registrant, in each case effective as of such date.
(c) Appointment of Robert J. Greczyn, Jr. as Interim President and Chief Executive Officer

On August 2, 2013, the Registrant announced the appointment of Robert J. Greczyn, Jr. as the Registrant's Interim President and Chief Executive Officer, effective as of August 1, 2013. In this role, Mr. Greczyn will serve as the Registrant's principal executive officer while the Registrant's Board of Directors conducts a search for a permanent successor to Mr. Brajer. There is no arrangement or understanding between Mr. Greczyn and any other person pursuant to which he was selected as an executive officer, and there is no family relationship between Mr. Greczyn and any of the Registrant's directors or other executive officers. The information required by Item 401(e) of Regulation S-K regarding Mr. Greczyn was previously reported in the Registrant's definitive proxy statement for its 2013 Annual Meeting of Stockholders, filed with the Securities and Exchange Commission on April 29, 2013 (the "Proxy Statement"), and is incorporated herein by reference.
Following his appointment as Interim President and Chief Executive Officer, Mr. Greczyn will continue as a member of the Board of Directors of the Registrant, although he is expected to resign from the Compensation Committee and the Audit Committee of the Board of Directors. Mr. Greczyn will continue to be compensated for his service as a director under the Registrant's director compensation policy, as described in the Proxy Statement. Mr. Greczyn will retain all equity awards previously granted in connection with his appointment as a director of the Registrant, which awards will continue to vest in accordance with their original terms. Any compensation in connection with Mr. Greczyn's interim appointment is under review by the Board of Directors. Item 7.01. Regulation FD Disclosure.
On August 2, 2013, the Registrant issued a press release announcing Mr. Brajer's departure and the appointment of Mr. Greczyn as Interim President and Chief Executive Officer. A copy of this press release is furnished herewith as Exhibit 99.2 to this Current Report.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits
    Exhibit
     Number                         Exhibit Description
      99.1           Press Release, dated August 6, 2013, "LipoScience
                       Reports Second Quarter 2013 Financial Results"
      99.2           Press Release, dated August 2, 2013, "LipoScience
                    Appoints Robert Greczyn Interim President and Chief
                                    Executive Officer."


  Add LPDX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for LPDX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.